Effects of rituximab treatment on the serum concentrations of vitamin D and interleukins 2, 6, 7, and 10 in patients with rheumatoid arthritis
Eman Hasan1, Samuel Olusi2, Adel Al-Awadhi3, Khalid Mokaddem1, Prem Sharma4, Sunila George21Rheumatic Disease Unit, Al-Amiri Hospital, Ministry of Health, Kuwait; 2Department of Pathology, Faculty of Medicine, Kuwait University, Kuwait; 3Department of Medicine, Faculty of Medicine, Kuwait University...
Guardado en:
Autores principales: | Hasan E, Olusi S, Al-Awadhi A, Mokaddem K, Sharma P, George S |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2012
|
Materias: | |
Acceso en línea: | https://doaj.org/article/7dd9ded1fade44c59ee08f16571fc738 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Update on the use of rituximab for intractable rheumatoid arthritis
por: R John Looney
Publicado: (2009) -
Rituximab therapy in Greek patients with rheumatoid arthritis
por: Haralampos M Moutsopoulos, et al.
Publicado: (2008) -
Tuberculosis Arthritis in the Wrist While Using Rituximab for Rheumatoid Arthritis Treatment
por: Ulusoy H, et al.
Publicado: (2020) -
B cell reductive therapy with rituximab in the treatment of rheumatoid arthritis
por: Joseph M Tuscano, et al.
Publicado: (2009) -
NK cell count as predictor of clinical response in patients with rheumatoid arthritis treated with rituximab
por: Re KA, et al.
Publicado: (2012)